Baolingbao Biology Co Ltd Cash Flow Conversion Efficiency
Baolingbao Biology Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Baolingbao Biology Co Ltd (002286) has a cash flow conversion efficiency ratio of 0.061x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥134.96 Million ≈ $19.75 Million USD) by net assets (CN¥2.20 Billion ≈ $322.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Baolingbao Biology Co Ltd (2006–2025)
Cash flow conversion efficiency of Baolingbao Biology Co Ltd from 2006 to 2025. This chart illustrates how Baolingbao Biology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Baolingbao Biology Co Ltd for real-time trading data and today's change.
Baolingbao Biology Co Ltd Cash Flow Conversion Ratio Explained
Baolingbao Biology Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Baolingbao Biology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Baolingbao Biology Co Ltd ranked by their cash flow conversion efficiency. Also see Baolingbao Biology Co Ltd market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Irish Residential Properties
IR:IRES
|
0.019x |
|
ScinoPharm Taiwan Ltd
TW:1789
|
0.019x |
|
Beijing Leadman Biochemistry Co Ltd
SHE:300289
|
0.007x |
|
Anpec Electronics
TWO:6138
|
0.041x |
|
Yorhe Fluid Intelligent Control Co Ltd
SHE:002795
|
0.106x |
|
First Foundation Inc.
NYSE:FFWM
|
-0.027x |
|
Caisse Regionale de Credit Agricole Mutuel de Normandie Seine SC
PA:CCN
|
0.003x |
|
Cheng Uei Precision Industry Co Ltd
TW:2392
|
0.146x |
Annual Cash Flow Conversion Efficiency for Baolingbao Biology Co Ltd (2006–2025)
The table below shows the annual cash flow conversion efficiency of Baolingbao Biology Co Ltd from 2006 to 2025. Review 002286 free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.23 Billion ≈ $326.85 Million |
CN¥259.36 Million ≈ $37.95 Million |
0.116x | -4.69% |
| 2024-12-31 | CN¥2.04 Billion ≈ $298.74 Million |
CN¥248.72 Million ≈ $36.40 Million |
0.122x | -14.39% |
| 2023-12-31 | CN¥1.98 Billion ≈ $290.25 Million |
CN¥282.28 Million ≈ $41.31 Million |
0.142x | +825.49% |
| 2022-12-31 | CN¥2.00 Billion ≈ $293.30 Million |
CN¥30.82 Million ≈ $4.51 Million |
0.015x | -86.48% |
| 2021-12-31 | CN¥1.81 Billion ≈ $265.33 Million |
CN¥206.27 Million ≈ $30.18 Million |
0.114x | -54.34% |
| 2020-12-31 | CN¥1.60 Billion ≈ $234.04 Million |
CN¥398.46 Million ≈ $58.31 Million |
0.249x | +153.58% |
| 2019-12-31 | CN¥1.57 Billion ≈ $229.30 Million |
CN¥153.95 Million ≈ $22.53 Million |
0.098x | +13.86% |
| 2018-12-31 | CN¥1.54 Billion ≈ $225.64 Million |
CN¥133.05 Million ≈ $19.47 Million |
0.086x | +456.56% |
| 2017-12-31 | CN¥1.53 Billion ≈ $223.17 Million |
CN¥-36.91 Million ≈ $-5.40 Million |
-0.024x | -133.49% |
| 2016-12-31 | CN¥1.51 Billion ≈ $220.69 Million |
CN¥108.98 Million ≈ $15.95 Million |
0.072x | +37.85% |
| 2015-12-31 | CN¥1.48 Billion ≈ $216.29 Million |
CN¥77.49 Million ≈ $11.34 Million |
0.052x | -25.34% |
| 2014-12-31 | CN¥1.45 Billion ≈ $212.09 Million |
CN¥101.77 Million ≈ $14.89 Million |
0.070x | +17.74% |
| 2013-12-31 | CN¥1.44 Billion ≈ $210.03 Million |
CN¥85.60 Million ≈ $12.53 Million |
0.060x | -48.22% |
| 2012-12-31 | CN¥817.45 Million ≈ $119.62 Million |
CN¥94.15 Million ≈ $13.78 Million |
0.115x | -48.98% |
| 2011-12-31 | CN¥760.53 Million ≈ $111.29 Million |
CN¥171.70 Million ≈ $25.12 Million |
0.226x | +478.31% |
| 2010-12-31 | CN¥703.11 Million ≈ $102.89 Million |
CN¥27.45 Million ≈ $4.02 Million |
0.039x | -41.88% |
| 2009-12-31 | CN¥662.61 Million ≈ $96.96 Million |
CN¥44.51 Million ≈ $6.51 Million |
0.067x | -85.56% |
| 2008-12-31 | CN¥238.05 Million ≈ $34.83 Million |
CN¥110.77 Million ≈ $16.21 Million |
0.465x | +13.88% |
| 2007-12-31 | CN¥193.28 Million ≈ $28.28 Million |
CN¥78.98 Million ≈ $11.56 Million |
0.409x | +140.46% |
| 2006-12-31 | CN¥112.53 Million ≈ $16.47 Million |
CN¥19.12 Million ≈ $2.80 Million |
0.170x | -- |
About Baolingbao Biology Co Ltd
Baolingbao Biology Co.,Ltd., together with its subsidiaries, engages in the research, development, manufacturing, and sale of functional sugar in China and internationally. The company offers prebiotics, including galacto-oligosaccharides, isomaltooligosaccharides, fructooligosaccharides, and xylooligosaccharides; sugar alcohols and sources, such as erythritol, trehalose, crystallized fructose, a… Read more